Deploying $10M into 22 category-defining AI companies at Pre-Seed and Seed. We move fast, invest with conviction, and build alongside our founders.
12x+
Target TVPI
30%+
Target IRR
$10M
Fund size
AI is not a standalone industry — it is an efficiency layer that creates the greatest value in regulated, asset-heavy sectors where incumbents are slow to move and must acquire or die. We target the trillion-dollar markets where AI-native companies will capture outsized returns.
Cost pressures, labor shortages, and regulatory friction create massive demand for AI infrastructure.
15+ unicorns created
The energy transition demands intelligent grid systems, predictive maintenance, and autonomous asset management.
8+ unicorns created
Carbon accounting and climate risk are no longer optional — they are enterprise imperatives.
6+ unicorns created
Global supply chains require intelligent automation to drive efficiency and eliminate waste at scale.
5+ unicorns created
Traditional venture capital models were designed for slower markets and broader mandates. In AI driven markets, intuition alone leads to mispricing, dilution, and missed inflection points. Precision VC was built to operate with greater discipline, focus, and adaptability.
Traditional VC
Precision VC
Precision VC invests at the pre seed and seed stages, then systematically follows its strongest performers at Series A. This approach maximizes early ownership while reserving capital to concentrate into companies that demonstrate traction.
22
Portfolio companies
60%
Initial deployment
40%
Follow on reserves
3 year
Investment period
The objective is not volume. The objective is ownership in outliers.
Portfolio math and power law
Venture returns are driven by a small number of companies. Precision VC focuses on improving hit rate and preserving ownership in those companies rather than spreading capital thinly across the portfolio.
Exit reality
Most successful venture outcomes occur through strategic acquisitions rather than public markets. Healthcare and energy incumbents are active acquirers with sustained demand for AI driven capabilities.
The relationships that put us in front of the right founders early, and in front of the right acquirers later.
Direct access to hospital systems, clinical leaders, and procurement decision makers.
Strategic relationships with incumbents driving acquisition and partnership activity.
Deal flow and talent pipelines from leading research institutions.
Early access to top tier founders and syndication partners.
Artificial intelligence runs everywhere in this fund except the one place that decides.
Decision support
Human led
Final investment decisions are made by people, with discipline and risk management prioritized over speed or volume.
We're looking for exceptional founders and aligned capital partners. If you're building something transformative, we want to hear from you.
Get in touchFor accredited investors only